Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Heterocyclic anticoagulants in development at BioChem Pharma

Oct. 15, 1998

Low-dose xemilofiban + high-dose ASA provides protection in canine arterial thrombosis model

Oct. 9, 1998

Sibrafiban interactions studied in canine model

Oct. 9, 1998

Rovi introduces LMW heparin in Spain

Oct. 7, 1998

Candidate gene therapy for hemophilia gives promising results in canine studies

Oct. 5, 1998

Potent, long-acting TxA2 receptor antagonist enters Pfizer development pipeline

Oct. 1, 1998

YM-377 as a treatment for coronary occlusive diseases

Sep. 29, 1998

U.S. patent issues for Bio-Technology General's anticoagulant polypeptide

Sep. 28, 1998

Organon designs nonpeptide thrombin inhibitors mimicking D-Phe-Pro-Arg

Sep. 25, 1998

Controlled clinical trial demonstrates efficacy of cilostazol in intermittent claudication

Sep. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...